Related Experiment Videos
Covalent binding of eicosanoids to platelet proteins
Prostaglandins
|July 1, 1986
Summary
Human platelets covalently bind arachidonic acid metabolites. This binding involves three distinct components, influenced by cyclooxygenase and lipoxygenase pathways, offering insights into platelet biochemistry.
Area of Science:
- Biochemistry
- Platelet Biology
- Pharmacology
Background:
- Human platelets metabolize arachidonic acid.
- A portion of these metabolites can bind to platelet proteins.
Purpose of the Study:
- To investigate the nature of arachidonic acid binding to human platelet proteins.
- To characterize the components of this binding using pharmacological agents.
Main Methods:
- Incubation of washed human platelets with 14C-arachidonic acid.
- Analysis of radioactivity in protein pellets using solvent extraction and SDS-PAGE.
- Assessment of binding components using inhibitors of cyclooxygenase and lipoxygenase pathways (indomethacin, eicosatetraynoic acid, dazoxiben, diamide).
Main Results:
- A small fraction of 14C-arachidonic acid became covalently bound to platelet proteins.
- Binding was resistant to solvent extraction and SDS-buffer dialysis.
- SDS-PAGE revealed labeling of several protein bands.
- Pharmacological agents identified three binding components: one independent of cyclooxygenase/lipoxygenase, one dependent on cyclooxygenase products, and one dependent on lipoxygenase products.
Conclusions:
- Human platelets exhibit covalent binding of arachidonic acid metabolites to proteins.
- This binding is complex and can be dissected into at least three distinct pathways.
- Understanding these pathways may elucidate mechanisms of platelet activation and function.